Forgot Password

Flat 25% discount on all reports exclusively for July & August 2018

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Biotechnology » HBI-3491016
  • Global Single Cell Analysis Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

  • Publish: October 2016 | Report Code: HBI-3491016

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

In the area of cellular biology, single-cell analysis means the study of separate cells isolated from tissues in multi-cellular organisms. The emerging applications of single cell analysis are in various fields such as drug discovery and development, particularly in oncology field, cancer immunotherapy, neurology and stem cells. The global single cell analysis market is estimated to have the CAGR of 18.5% during the forecast period 2016-2023. The rising demand of bio technology industry has become one of the key trends for the single-cell analysis market. Increasing technological advancements in single-cell analysis products, rising biotechnology and biopharmaceutical industries, increasing prevalence of infectious diseases across the globe are the major factors driving the global single cell analysis market. The unwillingness among researchers to accept advanced single-cell analysis products, high cost of instruments, issue related with intellectual property rights limit innovations in assay kits and stringent regulatory approval process may hamper the growth of global single cell analysis market.

Increasing technological advancements in single-cell analysis products, rising biotechnology and biopharmaceutical industries, increasing prevalence of infectious diseases across the globe are the major driving forces of the global single cell analysis market. The growing aging population in the world is major force that is creating huge growth opportunity in the global single cell analysis market. The global rise in chronic diseases, rising applications of single-cell analysis in cancer research and increased funding by government and private firms in research and development and increasing acceptance of stem cell technology is also driving the growth in global single cell analysis market. the growing aging population is one of the major driving factor which is injecting huge growth in global single cell analysis market. The world is currently on the edge of accomplishing a demographic milestone. Since the beginning of history being recorded, young children previously were ahead of the number of people aged 65 or more will go down in the coming future. This change is driven by falling fertility rates and remarkable rise in life expectancy, population aging is expected to continue, even accelerate in the next 10 years. The number of people aged 65 or older are anticipated to grow from an estimated $524 million in year 2010 to nearly 1.5% billion in year 2050, with most of the increase in developing countries. According to WHO the world aged population by the end of 2050 is expected to reach $2 billion that is $900 million in 2015. The remarkable improvements in life expectancy over the past century were part of a shift in the leading causes of disease and death. The rising prevalence of chronic life style oriented diseases is also increasing the growth in the global single cell analysis market. Cancer is the major disease which is increasing with a huge pace, according to WHO, by the end of 2020 there will be around $15 million people who are projected to suffer from cancer which increases by around 50%.

The global single cell analysis market has huge opportunities such as high growth opportunity in the emerging countries, growth potential in single-cell sequencing (SCS), fostering stem cell research, integration of micro fluidics in single-cell analysis and growing potential in emerging economies is expected to contribute a lot in the growth of global single cell analysis market.

Source: OBRC Analysis.

The report on global single cell analysis market includes cell type, end-user, application, technique and by product.

Product is segmented into:

  • Consumables
  • Instruments



Cell segment of single cell analysis includes:

  • Human Cells
  • Animal Cells
  • Microbial Cells




Technique segment of single cell analysis includes:

  • Flow Cytometry
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microscopy
  • Mass Spectrometry
  • Other Techniques







Application segment of single cell analysis includes:

  • Research Applications
  • Medical Applications



End-user segment of single cell analysis include:

  • Academic & Research Laboratories
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Cell Banks and IVF Centers





The revenue for the above application and end-user segments are specific to the single cell analysis market. However, the total revenue of these application and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up cell type and product segment.

The global single cell analysis market report has been geographically segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





The single cell analysis is segmented on the basis of application, cell type, product, end user, technique and geography. The application segment is segmented into research application and medical application. The medical application is further segmented into circulating tumour cells (CTCS), in vitro fertilization and non-invasive prenatal diagnosis. The research application is also sub segmented into cancer, immunology, neurology, stem cells and other applications. The end user segment is also segmented into biotechnology and biopharmaceutical companies, cell banks and IVF centres, hospitals and diagnostic laboratories and research & academic laboratories. The cell type segment is segmented into animal cells, human cells and microbial cells. The techniques segment is segmented into flow cytometry, mass spectrometry, microscopy, next-generation sequencing (NGS), PCR (Polymerase Chain Reaction) and other techniques. The product segment is further segmented into consumables and instruments.

The global single cell analysis market is driven by the presence of some the prominent player in the market. Becton, Dickinson and Company, Bioheart, Corning, Inc., Medtronic’s PLC, Celgene Corporation, GE Healthcare, illumine Inc., Merck KGAA, Stem cell Technologies, Stryker Corporation, Thermo Fisher Scientific, Inc

On the basis of geography North America, Europe, Asia Pacific and RoW are the major segments. North America dominates the single cell analysis market; the domination is due to presence of some key player of single cell analysis who invests a huge amount for the development of new technology in the single cell analysis which is increasing the North America share in the global single cell analysis market. The growth of north America is driven by number of factors such as growing aging population in the region, rising funding from private and government for new technological advancement in stem cell technology and tissue engineering. The rising demonstration of stem cell therapy for the treatment is also driving the growth in the North American single cell analysis market. Asia pacific market is expected to grow with a high CAGR in forecast period. The demand in the Asia Pacific is majorly driven by rising demand for stem cell therapies for the treatment due to increasing number of patient population in the region and increasing prevalence of chronic lifestyle diseases.

The major market players of the global single cell analysis market are:

  • AGILENT TECHNOLOGIES INC
  • GE HEALTHCARE
  • STRYKER CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • QIAGEN N.V.
  • OTHERS







These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, merger & acquisition is the key strategy adopted by the companies in the single cell analysis market.

For Example. In 2015, the Medtronic announced the acquisition of Covidien plc. which was an Irish-headquartered global health care products company and manufacturer and supplier of medical devices. This acquisition helped Medtronic to enhance the effectiveness if their healthcare product range and also assist the firm to expand their geographical presence.

The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in single cell analysis market.

Key reasons to buy the report:

  • The report includes market estimation, forecast and analysis for 2016-2023
  • Report includes detailed analysis of different segments such as application, end-user and product of global single cell analysis.
  • Identify and understand the strengths, opportunities, challenges and threat of the global single cell analysis market.
  • Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of global single cell analysis market.
  • Detailed analysis of various regulatory policies which affect the global single cell analysis market.






How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global single cell analysismarket offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the single cell analysis market, with giving extensive SCOT analysis of key companies. 

Key findings of the global single cell analysis market:

  • North America held highest revenue share in 2016.
  • Flow cytometry is expected to dominate the market.
  • Consumables of product segment is expected to dominate the market.
  • Acquisition is the key strategy adopted by players of global single cell analysis market. 

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL SINGLE-CELL ANALYSISMARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1.        TOP 5 FINDINGS

2.5.2.        TOP 5 OPPORTUNITY MARKETS

2.5.3.        TOP 5 COMPANIES

2.5.4.        TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1.        INVESTMENT VS. ADOPTION MODEL

2.7.2.        360-DEGREE INDUSTRY ANALYSIS

2.7.2.1.  PARENT MARKET ANALYSIS

2.7.2.2.  ALTERNATIVE MARKET

2.7.2.3.  COMPETITIVE MARKET

2.7.3.        PORTERS 5 FORCE MODEL

2.7.4.        SEE-SAW ANALYSIS

2.7.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1.        KEY STRATEGIES & ANALYSIS

2.8.2.        MARKET SHARE ANALYSIS AND TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS

3.1.2.        INCREASING GOVERNMENT FUNDING FOR CELL-BASED RESEARCH

3.1.3.        GROWING BIOTECHNOLOGY AND BIOPHARMACEUTICAL INDUSTRIES

3.1.4.        WIDE APPLICATIONS OF SINGLE-CELL ANALYSIS IN CANCER RESEARCH

3.1.5.        GROWING FOCUS ON PERSONALIZED MEDICINE

3.1.6.        INCREASING INCIDENCE AND PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES

3.2. MARKET RESTRAINTS

3.2.1.        HIGH COST OF SINGLE-CELL ANALYSIS PRODUCTS

3.3. MARKET OPPORTUNITIES

3.3.1.        GROWTH IN STEM CELL RESEARCH

3.3.2.        INTEGRATION OF MICROFLUIDICS IN SINGLE-CELL ANALYSIS

3.4. MARKET CHALLENGES

3.4.1.        SURVIVAL OF SMALL PLAYERS AND NEW ENTRANTS

4.      SINGLE-CELL ANALYSIS  MARKET BY PRODUCT

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL CONSUMABLES MARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  KEY PLAYERS  & KEY PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.1.5.  MARKET SUB SEGMENT

4.5.1.5.1.        BEADS

4.5.1.5.2.        MICROPLATES

4.5.1.5.3.        REAGENTS

4.5.1.5.4.        ASSAY KITS

4.5.1.5.4.1.   IMMUNOASSAYS

4.5.1.5.4.2.   CELL-BASED ASSAYS

4.5.1.5.4.3.   OTHER CONSUMABLES

4.5.2.      GLOBAL INSTRUMENTS MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  KEY PLAYERS  & KEY PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

4.5.2.5.  MARKET SUB SEGMENT

4.5.2.5.1.        FLOW CYTOMETERS

4.5.2.5.2.        NGS SYSTEMS

4.5.2.5.3.        PCR INSTRUMENTS

4.5.2.5.4.        SPECTROPHOTOMETERS

4.5.2.5.5.        MICROSCOPES

4.5.2.5.6.        CELL COUNTERS

4.5.2.5.7.        HCS SYSTEMS

4.5.2.5.8.        MICROARRAY SYSTEMS

4.5.2.5.9.        OTHER INSTRUMENTS

5.      SINGLE-CELL ANALYSIS MARKET BY CELL TYPE

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.  OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.      GLOBAL HUMAN CELLS MARKET

5.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3.  KEY PLAYERS  & KEY PRODUCTS

5.5.1.4.  KEY CONCLUSIONS

5.5.2.      GLOBAL ANIMAL CELLS MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  KEY PLAYERS  & KEY PRODUCTS

5.5.2.4.  KEY CONCLUSIONS

5.5.3.      GLOBAL MICROBIAL CELLS MARKET

5.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.3.3.  KEY PLAYERS  & KEY PRODUCTS

5.5.3.4.  KEY CONCLUSIONS

6.      SINGLE-CELL ANALYSIS MARKET BY TECHNIQUE

6.1. MARKET DEFINITION AND SCOPE

6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4.  OPPORTUNITY MATRIX

6.5. MARKET SEGMENTATION

6.5.1.      GLOBAL FLOW CYTOMETRY MARKET

6.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.1.3.  KEY PLAYERS  & KEY PRODUCTS

6.5.1.4.  KEY CONCLUSIONS

6.5.2.      GLOBAL NEXT-GENERATION SEQUENCING MARKET

6.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.2.3.  KEY PLAYERS  & KEY PRODUCTS

6.5.2.4.  KEY CONCLUSIONS

1.1.1.      GLOBAL POLYMERASE CHAIN REACTION MARKET

1.1.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.1.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.1.4.  KEY CONCLUSIONS

1.1.2.      GLOBAL MICROSCOPY MARKET

1.1.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.2.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.2.4.  KEY CONCLUSIONS

1.1.1.      GLOBAL MASS SPECTROMETRY MARKET

1.1.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.1.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.1.4.  KEY CONCLUSIONS

1.1.2.      GLOBAL OTHER TECHNIQUES MARKET

1.1.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.2.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.2.4.  KEY CONCLUSIONS

7.      SINGLE-CELL ANALYSIS MARKET BY APPLICATION

1.2. MARKET DEFINITION AND SCOPE

1.3. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

1.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

1.5.  OPPORTUNITY MATRIX

1.6. MARKET SEGMENTATION

1.6.1.      GLOBAL RESEARCH APPLICATIONS MARKET

1.6.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.6.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.6.1.3.  KEY PLAYERS  & KEY PRODUCTS

1.6.1.4.  KEY CONCLUSIONS

1.6.1.5.  MARKET SUB SEGMENT

1.6.1.5.1.        CANCER RESEARCH

1.6.1.5.2.        IMMUNOLOGY RESEARCH

1.6.1.5.3.        NEUROLOGY RESEARCH

1.6.1.5.4.        STEM CELL RESEARCH

1.6.1.5.5.        OTHER RESEARCH APPLICATIONS

1.6.2.      GLOBAL MEDICAL APPLICATIONS MARKET

1.6.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.6.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.6.2.3.  KEY PLAYERS  & KEY PRODUCTS

1.6.2.4.  KEY CONCLUSIONS

1.6.2.5.  MARKET SUB SEGMENT

1.6.2.5.1.        NON-INVASIVE PRENATAL DIAGNOSIS

1.6.2.5.2.        IN VITRO FERTILIZATION

1.6.2.5.3.        CIRCULATING TUMOR CELL DETECTION

8.      SINGLE-CELL ANALYSIS MARKET BY END USER

8.1. MARKET DEFINITION AND SCOPE

8.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

8.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

8.4.  OPPORTUNITY MATRIX

8.5. MARKET SEGMENTATION

8.5.1.      GLOBAL ACADEMIC & RESEARCH LABORATORIES MARKET

8.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.1.3.  KEY PLAYERS  & KEY PRODUCTS

8.5.1.4.  KEY CONCLUSIONS

8.5.2.      GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET

8.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.2.3.  KEY PLAYERS  & KEY PRODUCTS

8.5.2.4.  KEY CONCLUSIONS

8.5.3.      GLOBAL HOSPITALS AND DIAGNOSTIC LABORATORIES MARKET

8.5.3.1.  APPLICATION

8.5.3.2.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.3.3.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.3.4.  KEY PLAYERS  & KEY PRODUCTS

8.5.3.5.  KEY CONCLUSIONS

1.1.1.      GLOBAL CELL BANKS AND IVF CENTERS MARKET

1.1.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.1.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.2.        KEY CONCLUSIONS

2.       COMPETITIVE LANDSCAPE

2.1. KEY STRATEGIES

2.1.1.        LIST OF MERGERS AND ACQUISITION

2.1.2.        LIST OF JOINT VENTURES

2.1.3.        LIST OF PRODUCT LAUNCHES

2.1.4.        LIST OF PARTNERSHIPS

3.       GEOGRAPHICAL ANALYSIS

3.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

3.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

3.3. OPPORTUNITY MATRIX

3.4.                     GLOBAL SINGLE-CELL ANALYSIS MARKET BY REGION 2015-2024 ($ MILLION)

3.4.1.      NORTH AMERICA

3.4.1.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

3.4.1.2.  TOP COUNTRY ANALYSIS

3.4.1.2.1.      U.S.

3.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.1.2.1.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.1.2.1.3.   KEY CONCLUSIONS

3.4.1.2.2.      CANADA

3.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.1.2.2.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.1.2.2.3.   KEY CONCLUSIONS

3.4.2.      EUROPE

3.4.2.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

3.4.2.2.  TOP COUNTRY ANALYSIS

3.4.2.2.1.      UK

3.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.1.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.1.3.   KEY CONCLUSIONS

3.4.2.2.2.      FRANCE

3.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.2.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.2.3.   KEY CONCLUSIONS

3.4.2.2.3.      GERMANY

3.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.3.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.3.3.   KEY CONCLUSIONS

3.4.2.2.4.      SPAIN

3.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.4.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.4.3.   KEY CONCLUSIONS

3.4.2.2.5.      REST OF EUROPE

3.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.5.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.5.3.   KEY CONCLUSIONS

3.4.3.      ASIA PACIFIC

3.4.3.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

3.4.3.2.  TOP COUNTRY ANALYSIS

3.4.3.2.1.      CHINA

3.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.1.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.1.3.   KEY CONCLUSIONS

3.4.3.2.2.      INDIA

3.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.2.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.2.3.   KEY CONCLUSIONS

3.4.3.2.3.      JAPAN

3.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.3.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.3.3.   KEY CONCLUSIONS

3.4.3.2.4.      AUSTRALIA

3.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.4.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.4.3.   KEY CONCLUSIONS

3.4.3.2.5.      REST OF ASIA PACIFIC

3.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.5.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.5.3.   KEY CONCLUSIONS

3.4.4.      ROW

3.4.4.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

3.4.4.2.  TOP COUNTRY ANALYSIS

3.4.4.2.1.      LATIN AMERICA

3.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.4.2.1.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.4.2.1.3.   KEY CONCLUSIONS

3.4.4.2.2.      MIDDLE EAST & AFRICA

3.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.4.2.2.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.4.2.2.3.   KEY CONCLUSIONS

4.       COMPANY PROFILES

4.1. AGILENT TECHNOLOGIES INC (U.S.)

4.1.1.        OVERVIEW

4.1.2.        PRODUCT PORTFOLIO

4.1.3.        STRATEGIC INITIATIVES

4.1.4.        SCOT ANALYSIS

4.1.5.        STRATEGIC ANALYSIS

4.2. BECKMAN COULTER, INC. (U.S)

4.2.1.        OVERVIEW

4.2.2.        PRODUCT PORTFOLIO

4.2.3.        STRATEGIC INITIATIVES

4.2.4.        SCOT ANALYSIS

4.2.5.        STRATEGIC ANALYSIS

4.3. BECTON, DICKINSON AND COMPANY (U.S)

4.3.1.        OVERVIEW

4.3.2.        PRODUCT PORTFOLIO

4.3.3.        STRATEGIC INITIATIVES

4.3.4.        SCOT ANALYSIS

4.3.5.        STRATEGIC ANALYSIS

4.4. CORNING, INC. (U.S.)

4.4.1.        OVERVIEW

4.4.2.        PRODUCT PORTFOLIO

4.4.3.        STRATEGIC INITIATIVES

4.4.4.        SCOT ANALYSIS

4.4.5.        STRATEGIC ANALYSIS

4.5. MEDTRONIC’S PLC. (U.S.)

4.5.1.        OVERVIEW

4.5.2.        PRODUCT PORTFOLIO

4.5.3.        STRATEGIC INITIATIVES

4.5.4.        SCOT ANALYSIS

4.5.5.        STRATEGIC ANALYSIS

4.6. CELGENE CORPORATION (U.S)

4.6.1.        OVERVIEW

4.6.2.        PRODUCT PORTFOLIO

4.6.3.        STRATEGIC INITIATIVES

4.6.4.        SCOT ANALYSIS

4.6.5.        STRATEGIC ANALYSIS

4.7. GE HEALTHCARE (U.K.)

4.7.1.        OVERVIEW

4.7.2.        PRODUCT PORTFOLIO

4.7.3.        STRATEGIC INITIATIVES

4.7.4.        SCOT ANALYSIS

4.7.5.        STRATEGIC ANALYSIS

4.8. ILLUMINA INC. (U.S.)

4.8.1.        OVERVIEW

4.8.2.        PRODUCT PORTFOLIO

4.8.3.        STRATEGIC INITIATIVES

4.8.4.        SCOT ANALYSIS

4.8.5.        STRATEGIC ANALYSIS

4.9. MERCK KGAA (GERMANY)

4.9.1.        OVERVIEW

4.9.2.        PRODUCT PORTFOLIO

4.9.3.        STRATEGIC INITIATIVES

4.9.4.        SCOT ANALYSIS

4.9.5.        STRATEGIC ANALYSIS

4.10.                  MILTENYI BIOTEC (GERMANY)

4.10.1.   OVERVIEW

4.10.2.   PRODUCT PORTFOLIO

4.10.3.   STRATEGIC INITIATIVES

4.10.4.   SCOT ANALYSIS

4.10.5.   STRATEGIC ANALYSIS

4.11.                  NANOSTRING TECHNOLOGIES INC. (U.S.)

4.11.1.   OVERVIEW

4.11.2.   PRODUCT PORTFOLIO

4.11.3.   STRATEGIC INITIATIVES

4.11.4.   SCOT ANALYSIS

4.11.5.   STRATEGIC ANALYSIS

4.12.                  STEM CELL TECHNOLOGIES (CANADA)

4.12.1.   OVERVIEW

4.12.2.   PRODUCT PORTFOLIO

4.12.3.   STRATEGIC INITIATIVES

4.12.4.   SCOT ANALYSIS

4.12.5.   STRATEGIC ANALYSIS

4.13.                  STRYKER CORPORATION (U.SW)

4.13.1.   OVERVIEW

4.13.2.   PRODUCT PORTFOLIO

4.13.3.   STRATEGIC INITIATIVES

4.13.4.   SCOT ANALYSIS

4.13.5.   STRATEGIC ANALYSIS

4.14.                  THERMO FISHER SCIENTIFIC, INC (U.S.)

4.14.1.   OVERVIEW

4.14.2.   PRODUCT PORTFOLIO

4.14.3.   STRATEGIC INITIATIVES

4.14.4.   SCOT ANALYSIS

4.14.5.   STRATEGIC ANALYSIS

4.15.                  QIAGEN N.V (GERMANY)

4.15.1.   OVERVIEW

4.15.2.   PRODUCT PORTFOLIO

4.15.3.   STRATEGIC INITIATIVES

4.15.4.   SCOT ANALYSIS

4.15.5.   STRATEGIC ANALYSIS

4.15.6.    

LIST OF TABLES

1.       GLOBAL SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

2.       GLOBAL CONSUMABLES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL SINGLE-CELL ANALYSIS MARKET BY CONSUMABLES 2015-2024 ($ MILLION)

4.       GLOBAL SINGLE CELL ANALYSIS CONSUMABLES MARKET BY ASSAY KITS2015-2024 ($ MILLION)

5.       GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL SINGLE CELL ANALYSIS MARKET BY INSTRUMENTS 2015-2024 ($ MILLION)

7.       GLOBAL SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

8.       GLOBAL HUMAN CELLS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL ANIMAL CELLS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL MICROBIAL CELLS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL SINGLE-CELL ANALYSIS MARKET BY TECHNIQUES 2015-2024 ($ MILLION)

12.   GLOBAL FLOW CYTOMETRY  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

13.   GLOBAL NEXT-GENERATION SEQUENCING MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

14.   GLOBAL POLYMERASE CHAIN REACTION  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   GLOBAL MICROSCOPY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

16.   GLOBAL MASS SPECTROMETRY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

17.   GLOBAL OTHER TECHNIQUES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

18.   GLOBAL SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

19.   GLOBAL RESEARCH APPLICATIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

20.   GLOBAL SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATION 2015-2024 ($MILLION)

21.   GLOBAL MEDICAL APPLICATIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

22.   GLOBAL SINGLE CELL ANALYSIS MARKET BY MEDICAL APPLICATIONS 2015-2024 ($MILLION)

23.   GLOBAL SINGLE-CELL ANALYSIS MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)

24.   GLOBAL SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

25.   GLOBAL ACADEMIC & RESEARCH LABORATORIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

26.   GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

27.   GLOBAL HOSPITALS AND DIAGNOSTIC LABORATORIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

28.   GLOBAL CELL BANKS AND IVF CENTERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

29.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

30.   EUROPE SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

31.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

32.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

33.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

34.   EUROPE SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

35.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

36.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

37.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

38.   EUROPE SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

39.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

40.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

41.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY TRECHNIQUE 2015-2024 ($ MILLION)

42.   EUROPE SINGLE-CELL ANALYSIS MARKET BY TRECHNIQUE 2015-2024 ($ MILLION)

43.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY TRECHNIQUE 2015-2024 ($ MILLION)

44.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY TRECHNIQUE 2015-2024 ($ MILLION)

45.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

46.   EUROPE SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

47.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

48.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

49.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

50.   EUROPE SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

51.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

52.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

53.   UNITED STATES SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

54.   UNITED STATES SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

55.   CANADA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

56.   CANADA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

57.   UK SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

58.   UKSINGLE CELL ANALYSIS MARKET BY ROUTE OF END USER 2015-2024($ MILLION)

59.   GERMANY SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

60.   GERMANY SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

61.   FRANCE SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

62.   FRANCE SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

63.   SPAIN SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

64.   SPAIN SINGLE CELL ANALYSIS MARKET BY END USER   2015-2024($ MILLION)

65.   ROE SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

66.   ROE SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

67.   INDIA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

68.   INDIA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

69.   CHINA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

70.   CHINA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

71.   JAPAN SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

72.   JAPAN SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

73.   AUSTRALIA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

74.   AUSTRALIA SINGLE CELL ANALYSIS MARKET BY END USER  2015-2024($ MILLION)

75.   ROAPAC SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

76.   ROAPAC SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

77.   LATIN AMERICA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

78.   LATIN AMERICA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

79.   MENA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

80.   MENA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

LIST OF FIGURES

 

1.       GLOBAL CONSUMABLES MARKET 2015-2024 ($ MILLION)

2.       GLOBAL INSTRUMENTS MARKET 2015-2024 ($ MILLION)

3.       GLOBAL HUMAN CELLS MARKET 2015-2024 ($ MILLION)

4.       GLOBAL ANIMAL CELLS MARKET 2015-2024 ($ MILLION)

5.       GLOBAL MICROBIAL CELLS MARKET 2015-2024 ($ MILLION)

6.       GLOBAL FLOW CYTOMETRY  MARKET 2015-2024 ($ MILLION)

7.       GLOBAL NEXT-GENERATION SEQUENCING MARKET 2015-2024 ($ MILLION)

8.       GLOBAL POLYMERASE CHAIN REACTION  MARKET 2015-2024 ($ MILLION)

9.       GLOBAL MICROSCOPY MARKET 2015-2024 ($ MILLION)

10.   GLOBAL MASS SPECTROMETRY MARKET 2015-2024 ($ MILLION)

11.   GLOBAL OTHER TECHNIQUES MARKET 2015-2024 ($ MILLION)

12.   GLOBAL RESEARCH APPLICATIONS MARKET 2015-2024 ($ MILLION)

13.   GLOBAL MEDICAL APPLICATIONS MARKET 2015-2024 ($ MILLION)

14.   GLOBAL ACADEMIC & RESEARCH LABORATORIES MARKET 2015-2024 ($ MILLION)

15.   GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET 2015-2024 ($ MILLION)

16.   GLOBAL HOSPITALS AND DIAGNOSTIC LABORATORIES MARKET 2015-2024 ($ MILLION)

17.   GLOBAL CELL BANKS AND IVF CENTERS MARKET 2015-2024 ($ MILLION)

18.   UNITED STATES (U.S.) SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

19.   CANADA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

20.   UNITED KINGDOM (UK) SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

21.   FRANCE SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

22.   GERMANY SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

23.   SPAIN SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

24.   ROE SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

25.   INDIA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

26.   CHINA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

27.   JAPAN SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

28.   AUSTRALIA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

29.   ROAPAC SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

30.   LATIN AMERICA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

31.   MENA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Biotechnology » HBI-3491016
  • Global Single Cell Analysis Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

  • Publish: October 2016 | Report Code: HBI-3491016

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

In the area of cellular biology, single-cell analysis means the study of separate cells isolated from tissues in multi-cellular organisms. The emerging applications of single cell analysis are in various fields such as drug discovery and development, particularly in oncology field, cancer immunotherapy, neurology and stem cells. The global single cell analysis market is estimated to have the CAGR of 18.5% during the forecast period 2016-2023. The rising demand of bio technology industry has become one of the key trends for the single-cell analysis market. Increasing technological advancements in single-cell analysis products, rising biotechnology and biopharmaceutical industries, increasing prevalence of infectious diseases across the globe are the major factors driving the global single cell analysis market. The unwillingness among researchers to accept advanced single-cell analysis products, high cost of instruments, issue related with intellectual property rights limit innovations in assay kits and stringent regulatory approval process may hamper the growth of global single cell analysis market.

Increasing technological advancements in single-cell analysis products, rising biotechnology and biopharmaceutical industries, increasing prevalence of infectious diseases across the globe are the major driving forces of the global single cell analysis market. The growing aging population in the world is major force that is creating huge growth opportunity in the global single cell analysis market. The global rise in chronic diseases, rising applications of single-cell analysis in cancer research and increased funding by government and private firms in research and development and increasing acceptance of stem cell technology is also driving the growth in global single cell analysis market. the growing aging population is one of the major driving factor which is injecting huge growth in global single cell analysis market. The world is currently on the edge of accomplishing a demographic milestone. Since the beginning of history being recorded, young children previously were ahead of the number of people aged 65 or more will go down in the coming future. This change is driven by falling fertility rates and remarkable rise in life expectancy, population aging is expected to continue, even accelerate in the next 10 years. The number of people aged 65 or older are anticipated to grow from an estimated $524 million in year 2010 to nearly 1.5% billion in year 2050, with most of the increase in developing countries. According to WHO the world aged population by the end of 2050 is expected to reach $2 billion that is $900 million in 2015. The remarkable improvements in life expectancy over the past century were part of a shift in the leading causes of disease and death. The rising prevalence of chronic life style oriented diseases is also increasing the growth in the global single cell analysis market. Cancer is the major disease which is increasing with a huge pace, according to WHO, by the end of 2020 there will be around $15 million people who are projected to suffer from cancer which increases by around 50%.

The global single cell analysis market has huge opportunities such as high growth opportunity in the emerging countries, growth potential in single-cell sequencing (SCS), fostering stem cell research, integration of micro fluidics in single-cell analysis and growing potential in emerging economies is expected to contribute a lot in the growth of global single cell analysis market.

Source: OBRC Analysis.

The report on global single cell analysis market includes cell type, end-user, application, technique and by product.

Product is segmented into:

  • Consumables
  • Instruments



Cell segment of single cell analysis includes:

  • Human Cells
  • Animal Cells
  • Microbial Cells




Technique segment of single cell analysis includes:

  • Flow Cytometry
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microscopy
  • Mass Spectrometry
  • Other Techniques







Application segment of single cell analysis includes:

  • Research Applications
  • Medical Applications



End-user segment of single cell analysis include:

  • Academic & Research Laboratories
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Cell Banks and IVF Centers





The revenue for the above application and end-user segments are specific to the single cell analysis market. However, the total revenue of these application and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up cell type and product segment.

The global single cell analysis market report has been geographically segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





The single cell analysis is segmented on the basis of application, cell type, product, end user, technique and geography. The application segment is segmented into research application and medical application. The medical application is further segmented into circulating tumour cells (CTCS), in vitro fertilization and non-invasive prenatal diagnosis. The research application is also sub segmented into cancer, immunology, neurology, stem cells and other applications. The end user segment is also segmented into biotechnology and biopharmaceutical companies, cell banks and IVF centres, hospitals and diagnostic laboratories and research & academic laboratories. The cell type segment is segmented into animal cells, human cells and microbial cells. The techniques segment is segmented into flow cytometry, mass spectrometry, microscopy, next-generation sequencing (NGS), PCR (Polymerase Chain Reaction) and other techniques. The product segment is further segmented into consumables and instruments.

The global single cell analysis market is driven by the presence of some the prominent player in the market. Becton, Dickinson and Company, Bioheart, Corning, Inc., Medtronic’s PLC, Celgene Corporation, GE Healthcare, illumine Inc., Merck KGAA, Stem cell Technologies, Stryker Corporation, Thermo Fisher Scientific, Inc

On the basis of geography North America, Europe, Asia Pacific and RoW are the major segments. North America dominates the single cell analysis market; the domination is due to presence of some key player of single cell analysis who invests a huge amount for the development of new technology in the single cell analysis which is increasing the North America share in the global single cell analysis market. The growth of north America is driven by number of factors such as growing aging population in the region, rising funding from private and government for new technological advancement in stem cell technology and tissue engineering. The rising demonstration of stem cell therapy for the treatment is also driving the growth in the North American single cell analysis market. Asia pacific market is expected to grow with a high CAGR in forecast period. The demand in the Asia Pacific is majorly driven by rising demand for stem cell therapies for the treatment due to increasing number of patient population in the region and increasing prevalence of chronic lifestyle diseases.

The major market players of the global single cell analysis market are:

  • AGILENT TECHNOLOGIES INC
  • GE HEALTHCARE
  • STRYKER CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • QIAGEN N.V.
  • OTHERS







These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, merger & acquisition is the key strategy adopted by the companies in the single cell analysis market.

For Example. In 2015, the Medtronic announced the acquisition of Covidien plc. which was an Irish-headquartered global health care products company and manufacturer and supplier of medical devices. This acquisition helped Medtronic to enhance the effectiveness if their healthcare product range and also assist the firm to expand their geographical presence.

The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in single cell analysis market.

Key reasons to buy the report:

  • The report includes market estimation, forecast and analysis for 2016-2023
  • Report includes detailed analysis of different segments such as application, end-user and product of global single cell analysis.
  • Identify and understand the strengths, opportunities, challenges and threat of the global single cell analysis market.
  • Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of global single cell analysis market.
  • Detailed analysis of various regulatory policies which affect the global single cell analysis market.






How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global single cell analysismarket offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the single cell analysis market, with giving extensive SCOT analysis of key companies. 

Key findings of the global single cell analysis market:

  • North America held highest revenue share in 2016.
  • Flow cytometry is expected to dominate the market.
  • Consumables of product segment is expected to dominate the market.
  • Acquisition is the key strategy adopted by players of global single cell analysis market. 

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL SINGLE-CELL ANALYSISMARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1.        TOP 5 FINDINGS

2.5.2.        TOP 5 OPPORTUNITY MARKETS

2.5.3.        TOP 5 COMPANIES

2.5.4.        TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1.        INVESTMENT VS. ADOPTION MODEL

2.7.2.        360-DEGREE INDUSTRY ANALYSIS

2.7.2.1.  PARENT MARKET ANALYSIS

2.7.2.2.  ALTERNATIVE MARKET

2.7.2.3.  COMPETITIVE MARKET

2.7.3.        PORTERS 5 FORCE MODEL

2.7.4.        SEE-SAW ANALYSIS

2.7.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1.        KEY STRATEGIES & ANALYSIS

2.8.2.        MARKET SHARE ANALYSIS AND TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS

3.1.2.        INCREASING GOVERNMENT FUNDING FOR CELL-BASED RESEARCH

3.1.3.        GROWING BIOTECHNOLOGY AND BIOPHARMACEUTICAL INDUSTRIES

3.1.4.        WIDE APPLICATIONS OF SINGLE-CELL ANALYSIS IN CANCER RESEARCH

3.1.5.        GROWING FOCUS ON PERSONALIZED MEDICINE

3.1.6.        INCREASING INCIDENCE AND PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES

3.2. MARKET RESTRAINTS

3.2.1.        HIGH COST OF SINGLE-CELL ANALYSIS PRODUCTS

3.3. MARKET OPPORTUNITIES

3.3.1.        GROWTH IN STEM CELL RESEARCH

3.3.2.        INTEGRATION OF MICROFLUIDICS IN SINGLE-CELL ANALYSIS

3.4. MARKET CHALLENGES

3.4.1.        SURVIVAL OF SMALL PLAYERS AND NEW ENTRANTS

4.      SINGLE-CELL ANALYSIS  MARKET BY PRODUCT

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL CONSUMABLES MARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  KEY PLAYERS  & KEY PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.1.5.  MARKET SUB SEGMENT

4.5.1.5.1.        BEADS

4.5.1.5.2.        MICROPLATES

4.5.1.5.3.        REAGENTS

4.5.1.5.4.        ASSAY KITS

4.5.1.5.4.1.   IMMUNOASSAYS

4.5.1.5.4.2.   CELL-BASED ASSAYS

4.5.1.5.4.3.   OTHER CONSUMABLES

4.5.2.      GLOBAL INSTRUMENTS MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  KEY PLAYERS  & KEY PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

4.5.2.5.  MARKET SUB SEGMENT

4.5.2.5.1.        FLOW CYTOMETERS

4.5.2.5.2.        NGS SYSTEMS

4.5.2.5.3.        PCR INSTRUMENTS

4.5.2.5.4.        SPECTROPHOTOMETERS

4.5.2.5.5.        MICROSCOPES

4.5.2.5.6.        CELL COUNTERS

4.5.2.5.7.        HCS SYSTEMS

4.5.2.5.8.        MICROARRAY SYSTEMS

4.5.2.5.9.        OTHER INSTRUMENTS

5.      SINGLE-CELL ANALYSIS MARKET BY CELL TYPE

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.  OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.      GLOBAL HUMAN CELLS MARKET

5.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3.  KEY PLAYERS  & KEY PRODUCTS

5.5.1.4.  KEY CONCLUSIONS

5.5.2.      GLOBAL ANIMAL CELLS MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  KEY PLAYERS  & KEY PRODUCTS

5.5.2.4.  KEY CONCLUSIONS

5.5.3.      GLOBAL MICROBIAL CELLS MARKET

5.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.3.3.  KEY PLAYERS  & KEY PRODUCTS

5.5.3.4.  KEY CONCLUSIONS

6.      SINGLE-CELL ANALYSIS MARKET BY TECHNIQUE

6.1. MARKET DEFINITION AND SCOPE

6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4.  OPPORTUNITY MATRIX

6.5. MARKET SEGMENTATION

6.5.1.      GLOBAL FLOW CYTOMETRY MARKET

6.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.1.3.  KEY PLAYERS  & KEY PRODUCTS

6.5.1.4.  KEY CONCLUSIONS

6.5.2.      GLOBAL NEXT-GENERATION SEQUENCING MARKET

6.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.2.3.  KEY PLAYERS  & KEY PRODUCTS

6.5.2.4.  KEY CONCLUSIONS

1.1.1.      GLOBAL POLYMERASE CHAIN REACTION MARKET

1.1.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.1.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.1.4.  KEY CONCLUSIONS

1.1.2.      GLOBAL MICROSCOPY MARKET

1.1.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.2.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.2.4.  KEY CONCLUSIONS

1.1.1.      GLOBAL MASS SPECTROMETRY MARKET

1.1.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.1.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.1.4.  KEY CONCLUSIONS

1.1.2.      GLOBAL OTHER TECHNIQUES MARKET

1.1.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.2.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.2.4.  KEY CONCLUSIONS

7.      SINGLE-CELL ANALYSIS MARKET BY APPLICATION

1.2. MARKET DEFINITION AND SCOPE

1.3. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

1.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

1.5.  OPPORTUNITY MATRIX

1.6. MARKET SEGMENTATION

1.6.1.      GLOBAL RESEARCH APPLICATIONS MARKET

1.6.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.6.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.6.1.3.  KEY PLAYERS  & KEY PRODUCTS

1.6.1.4.  KEY CONCLUSIONS

1.6.1.5.  MARKET SUB SEGMENT

1.6.1.5.1.        CANCER RESEARCH

1.6.1.5.2.        IMMUNOLOGY RESEARCH

1.6.1.5.3.        NEUROLOGY RESEARCH

1.6.1.5.4.        STEM CELL RESEARCH

1.6.1.5.5.        OTHER RESEARCH APPLICATIONS

1.6.2.      GLOBAL MEDICAL APPLICATIONS MARKET

1.6.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.6.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.6.2.3.  KEY PLAYERS  & KEY PRODUCTS

1.6.2.4.  KEY CONCLUSIONS

1.6.2.5.  MARKET SUB SEGMENT

1.6.2.5.1.        NON-INVASIVE PRENATAL DIAGNOSIS

1.6.2.5.2.        IN VITRO FERTILIZATION

1.6.2.5.3.        CIRCULATING TUMOR CELL DETECTION

8.      SINGLE-CELL ANALYSIS MARKET BY END USER

8.1. MARKET DEFINITION AND SCOPE

8.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

8.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

8.4.  OPPORTUNITY MATRIX

8.5. MARKET SEGMENTATION

8.5.1.      GLOBAL ACADEMIC & RESEARCH LABORATORIES MARKET

8.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.1.3.  KEY PLAYERS  & KEY PRODUCTS

8.5.1.4.  KEY CONCLUSIONS

8.5.2.      GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET

8.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.2.3.  KEY PLAYERS  & KEY PRODUCTS

8.5.2.4.  KEY CONCLUSIONS

8.5.3.      GLOBAL HOSPITALS AND DIAGNOSTIC LABORATORIES MARKET

8.5.3.1.  APPLICATION

8.5.3.2.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.5.3.3.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.5.3.4.  KEY PLAYERS  & KEY PRODUCTS

8.5.3.5.  KEY CONCLUSIONS

1.1.1.      GLOBAL CELL BANKS AND IVF CENTERS MARKET

1.1.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

1.1.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

1.1.1.3.  KEY PLAYERS  & KEY PRODUCTS

1.1.2.        KEY CONCLUSIONS

2.       COMPETITIVE LANDSCAPE

2.1. KEY STRATEGIES

2.1.1.        LIST OF MERGERS AND ACQUISITION

2.1.2.        LIST OF JOINT VENTURES

2.1.3.        LIST OF PRODUCT LAUNCHES

2.1.4.        LIST OF PARTNERSHIPS

3.       GEOGRAPHICAL ANALYSIS

3.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

3.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

3.3. OPPORTUNITY MATRIX

3.4.                     GLOBAL SINGLE-CELL ANALYSIS MARKET BY REGION 2015-2024 ($ MILLION)

3.4.1.      NORTH AMERICA

3.4.1.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

3.4.1.2.  TOP COUNTRY ANALYSIS

3.4.1.2.1.      U.S.

3.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.1.2.1.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.1.2.1.3.   KEY CONCLUSIONS

3.4.1.2.2.      CANADA

3.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.1.2.2.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.1.2.2.3.   KEY CONCLUSIONS

3.4.2.      EUROPE

3.4.2.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

3.4.2.2.  TOP COUNTRY ANALYSIS

3.4.2.2.1.      UK

3.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.1.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.1.3.   KEY CONCLUSIONS

3.4.2.2.2.      FRANCE

3.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.2.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.2.3.   KEY CONCLUSIONS

3.4.2.2.3.      GERMANY

3.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.3.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.3.3.   KEY CONCLUSIONS

3.4.2.2.4.      SPAIN

3.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.4.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.4.3.   KEY CONCLUSIONS

3.4.2.2.5.      REST OF EUROPE

3.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.2.2.5.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.2.2.5.3.   KEY CONCLUSIONS

3.4.3.      ASIA PACIFIC

3.4.3.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

3.4.3.2.  TOP COUNTRY ANALYSIS

3.4.3.2.1.      CHINA

3.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.1.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.1.3.   KEY CONCLUSIONS

3.4.3.2.2.      INDIA

3.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.2.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.2.3.   KEY CONCLUSIONS

3.4.3.2.3.      JAPAN

3.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.3.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.3.3.   KEY CONCLUSIONS

3.4.3.2.4.      AUSTRALIA

3.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.4.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.4.3.   KEY CONCLUSIONS

3.4.3.2.5.      REST OF ASIA PACIFIC

3.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.3.2.5.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.3.2.5.3.   KEY CONCLUSIONS

3.4.4.      ROW

3.4.4.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

3.4.4.2.  TOP COUNTRY ANALYSIS

3.4.4.2.1.      LATIN AMERICA

3.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.4.2.1.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.4.2.1.3.   KEY CONCLUSIONS

3.4.4.2.2.      MIDDLE EAST & AFRICA

3.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

3.4.4.2.2.2.   KEY PLAYERS  & KEY PRODUCTS

3.4.4.2.2.3.   KEY CONCLUSIONS

4.       COMPANY PROFILES

4.1. AGILENT TECHNOLOGIES INC (U.S.)

4.1.1.        OVERVIEW

4.1.2.        PRODUCT PORTFOLIO

4.1.3.        STRATEGIC INITIATIVES

4.1.4.        SCOT ANALYSIS

4.1.5.        STRATEGIC ANALYSIS

4.2. BECKMAN COULTER, INC. (U.S)

4.2.1.        OVERVIEW

4.2.2.        PRODUCT PORTFOLIO

4.2.3.        STRATEGIC INITIATIVES

4.2.4.        SCOT ANALYSIS

4.2.5.        STRATEGIC ANALYSIS

4.3. BECTON, DICKINSON AND COMPANY (U.S)

4.3.1.        OVERVIEW

4.3.2.        PRODUCT PORTFOLIO

4.3.3.        STRATEGIC INITIATIVES

4.3.4.        SCOT ANALYSIS

4.3.5.        STRATEGIC ANALYSIS

4.4. CORNING, INC. (U.S.)

4.4.1.        OVERVIEW

4.4.2.        PRODUCT PORTFOLIO

4.4.3.        STRATEGIC INITIATIVES

4.4.4.        SCOT ANALYSIS

4.4.5.        STRATEGIC ANALYSIS

4.5. MEDTRONIC’S PLC. (U.S.)

4.5.1.        OVERVIEW

4.5.2.        PRODUCT PORTFOLIO

4.5.3.        STRATEGIC INITIATIVES

4.5.4.        SCOT ANALYSIS

4.5.5.        STRATEGIC ANALYSIS

4.6. CELGENE CORPORATION (U.S)

4.6.1.        OVERVIEW

4.6.2.        PRODUCT PORTFOLIO

4.6.3.        STRATEGIC INITIATIVES

4.6.4.        SCOT ANALYSIS

4.6.5.        STRATEGIC ANALYSIS

4.7. GE HEALTHCARE (U.K.)

4.7.1.        OVERVIEW

4.7.2.        PRODUCT PORTFOLIO

4.7.3.        STRATEGIC INITIATIVES

4.7.4.        SCOT ANALYSIS

4.7.5.        STRATEGIC ANALYSIS

4.8. ILLUMINA INC. (U.S.)

4.8.1.        OVERVIEW

4.8.2.        PRODUCT PORTFOLIO

4.8.3.        STRATEGIC INITIATIVES

4.8.4.        SCOT ANALYSIS

4.8.5.        STRATEGIC ANALYSIS

4.9. MERCK KGAA (GERMANY)

4.9.1.        OVERVIEW

4.9.2.        PRODUCT PORTFOLIO

4.9.3.        STRATEGIC INITIATIVES

4.9.4.        SCOT ANALYSIS

4.9.5.        STRATEGIC ANALYSIS

4.10.                  MILTENYI BIOTEC (GERMANY)

4.10.1.   OVERVIEW

4.10.2.   PRODUCT PORTFOLIO

4.10.3.   STRATEGIC INITIATIVES

4.10.4.   SCOT ANALYSIS

4.10.5.   STRATEGIC ANALYSIS

4.11.                  NANOSTRING TECHNOLOGIES INC. (U.S.)

4.11.1.   OVERVIEW

4.11.2.   PRODUCT PORTFOLIO

4.11.3.   STRATEGIC INITIATIVES

4.11.4.   SCOT ANALYSIS

4.11.5.   STRATEGIC ANALYSIS

4.12.                  STEM CELL TECHNOLOGIES (CANADA)

4.12.1.   OVERVIEW

4.12.2.   PRODUCT PORTFOLIO

4.12.3.   STRATEGIC INITIATIVES

4.12.4.   SCOT ANALYSIS

4.12.5.   STRATEGIC ANALYSIS

4.13.                  STRYKER CORPORATION (U.SW)

4.13.1.   OVERVIEW

4.13.2.   PRODUCT PORTFOLIO

4.13.3.   STRATEGIC INITIATIVES

4.13.4.   SCOT ANALYSIS

4.13.5.   STRATEGIC ANALYSIS

4.14.                  THERMO FISHER SCIENTIFIC, INC (U.S.)

4.14.1.   OVERVIEW

4.14.2.   PRODUCT PORTFOLIO

4.14.3.   STRATEGIC INITIATIVES

4.14.4.   SCOT ANALYSIS

4.14.5.   STRATEGIC ANALYSIS

4.15.                  QIAGEN N.V (GERMANY)

4.15.1.   OVERVIEW

4.15.2.   PRODUCT PORTFOLIO

4.15.3.   STRATEGIC INITIATIVES

4.15.4.   SCOT ANALYSIS

4.15.5.   STRATEGIC ANALYSIS

4.15.6.    

LIST OF TABLES

1.       GLOBAL SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

2.       GLOBAL CONSUMABLES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL SINGLE-CELL ANALYSIS MARKET BY CONSUMABLES 2015-2024 ($ MILLION)

4.       GLOBAL SINGLE CELL ANALYSIS CONSUMABLES MARKET BY ASSAY KITS2015-2024 ($ MILLION)

5.       GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL SINGLE CELL ANALYSIS MARKET BY INSTRUMENTS 2015-2024 ($ MILLION)

7.       GLOBAL SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

8.       GLOBAL HUMAN CELLS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL ANIMAL CELLS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL MICROBIAL CELLS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL SINGLE-CELL ANALYSIS MARKET BY TECHNIQUES 2015-2024 ($ MILLION)

12.   GLOBAL FLOW CYTOMETRY  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

13.   GLOBAL NEXT-GENERATION SEQUENCING MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

14.   GLOBAL POLYMERASE CHAIN REACTION  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   GLOBAL MICROSCOPY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

16.   GLOBAL MASS SPECTROMETRY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

17.   GLOBAL OTHER TECHNIQUES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

18.   GLOBAL SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

19.   GLOBAL RESEARCH APPLICATIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

20.   GLOBAL SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATION 2015-2024 ($MILLION)

21.   GLOBAL MEDICAL APPLICATIONS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

22.   GLOBAL SINGLE CELL ANALYSIS MARKET BY MEDICAL APPLICATIONS 2015-2024 ($MILLION)

23.   GLOBAL SINGLE-CELL ANALYSIS MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)

24.   GLOBAL SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

25.   GLOBAL ACADEMIC & RESEARCH LABORATORIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

26.   GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

27.   GLOBAL HOSPITALS AND DIAGNOSTIC LABORATORIES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

28.   GLOBAL CELL BANKS AND IVF CENTERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

29.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

30.   EUROPE SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

31.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

32.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

33.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

34.   EUROPE SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

35.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

36.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY PRODUCT 2015-2024 ($ MILLION)

37.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

38.   EUROPE SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

39.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

40.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY CELL TYPE 2015-2024 ($ MILLION)

41.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY TRECHNIQUE 2015-2024 ($ MILLION)

42.   EUROPE SINGLE-CELL ANALYSIS MARKET BY TRECHNIQUE 2015-2024 ($ MILLION)

43.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY TRECHNIQUE 2015-2024 ($ MILLION)

44.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY TRECHNIQUE 2015-2024 ($ MILLION)

45.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

46.   EUROPE SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

47.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

48.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY APPLICATION 2015-2024 ($ MILLION)

49.   NORTH AMERICA SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

50.   EUROPE SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

51.   ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

52.   REST OF THE WORLD SINGLE-CELL ANALYSIS MARKET BY END USER 2015-2024 ($ MILLION)

53.   UNITED STATES SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

54.   UNITED STATES SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

55.   CANADA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

56.   CANADA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

57.   UK SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

58.   UKSINGLE CELL ANALYSIS MARKET BY ROUTE OF END USER 2015-2024($ MILLION)

59.   GERMANY SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

60.   GERMANY SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

61.   FRANCE SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

62.   FRANCE SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

63.   SPAIN SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

64.   SPAIN SINGLE CELL ANALYSIS MARKET BY END USER   2015-2024($ MILLION)

65.   ROE SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

66.   ROE SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

67.   INDIA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

68.   INDIA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

69.   CHINA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

70.   CHINA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

71.   JAPAN SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

72.   JAPAN SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

73.   AUSTRALIA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

74.   AUSTRALIA SINGLE CELL ANALYSIS MARKET BY END USER  2015-2024($ MILLION)

75.   ROAPAC SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

76.   ROAPAC SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

77.   LATIN AMERICA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

78.   LATIN AMERICA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

79.   MENA SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2015-2024($ MILLION)

80.   MENA SINGLE CELL ANALYSIS MARKET BY END USER 2015-2024($ MILLION)

LIST OF FIGURES

 

1.       GLOBAL CONSUMABLES MARKET 2015-2024 ($ MILLION)

2.       GLOBAL INSTRUMENTS MARKET 2015-2024 ($ MILLION)

3.       GLOBAL HUMAN CELLS MARKET 2015-2024 ($ MILLION)

4.       GLOBAL ANIMAL CELLS MARKET 2015-2024 ($ MILLION)

5.       GLOBAL MICROBIAL CELLS MARKET 2015-2024 ($ MILLION)

6.       GLOBAL FLOW CYTOMETRY  MARKET 2015-2024 ($ MILLION)

7.       GLOBAL NEXT-GENERATION SEQUENCING MARKET 2015-2024 ($ MILLION)

8.       GLOBAL POLYMERASE CHAIN REACTION  MARKET 2015-2024 ($ MILLION)

9.       GLOBAL MICROSCOPY MARKET 2015-2024 ($ MILLION)

10.   GLOBAL MASS SPECTROMETRY MARKET 2015-2024 ($ MILLION)

11.   GLOBAL OTHER TECHNIQUES MARKET 2015-2024 ($ MILLION)

12.   GLOBAL RESEARCH APPLICATIONS MARKET 2015-2024 ($ MILLION)

13.   GLOBAL MEDICAL APPLICATIONS MARKET 2015-2024 ($ MILLION)

14.   GLOBAL ACADEMIC & RESEARCH LABORATORIES MARKET 2015-2024 ($ MILLION)

15.   GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET 2015-2024 ($ MILLION)

16.   GLOBAL HOSPITALS AND DIAGNOSTIC LABORATORIES MARKET 2015-2024 ($ MILLION)

17.   GLOBAL CELL BANKS AND IVF CENTERS MARKET 2015-2024 ($ MILLION)

18.   UNITED STATES (U.S.) SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

19.   CANADA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

20.   UNITED KINGDOM (UK) SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

21.   FRANCE SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

22.   GERMANY SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

23.   SPAIN SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

24.   ROE SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

25.   INDIA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

26.   CHINA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

27.   JAPAN SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

28.   AUSTRALIA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

29.   ROAPAC SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

30.   LATIN AMERICA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

31.   MENA SINGLE-CELL ANALYSIS MARKET 2015-2024 ($ MILLION)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion